Companies / ATX

AMPLIA THERAPEUTICS LIMITED

ASX:ATXPharmaceuticals, Biotechnology & Life Sciences
513.3M shares on issueASX (delayed) · snapshot 28 Oct 2026620.5M fully diluted+20.9% if every option and right converts$0.083price · delayed$40.6MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 82.7% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Share count grew 87% in 24 months; runway 4–8 quarters; 2 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway7.6 quarters of funding
Share-count growth (24m)86.8%
Raise cadence (24m)2 cash raises
Options & rights overhang20.9% of shares
In-the-money supplyno data — an exercise price is on record for a minority of the supply
Pending proposed issuesnone

AMPLIA THERAPEUTICS LIMITED's ordinary share count grew 86.8% between August 2024 and May 2026, its latest share-count filing, to 513M shares. The company raised capital twice in the 24-month window for total proceeds of A$40.7M, most recently a Placement and Share Purchase Plan in July 2025 raising A$27.6M. Options and rights on issue could convert into 107M new shares, equal to 20.9% of the current share count. None are currently in the money. The nearest expiry is in October 2027. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues are pending.

AI-generated summary of this page's cited filings · updated 28 Oct 2026
Quick answers · 5

When did ATX last raise capital?

The last capital raise in Amplia Therapeutics's filings is Placement and Share Purchase Plan of $27.6M announced 23 July 2025, one of 2 cash raises in 24 months.

How much placement capacity does ATX have left?

None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much cash does ATX have?

In its quarterly cash report for the quarter ended 30 Sept 2026, Amplia Therapeutics reported $20.8M of cash and estimated 6.7 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do ATX's options expire?

Unexercised options and rights equal 20.9% of Amplia Therapeutics's shares on issue; the nearest expiry is Oct 2027.

How much has ATX's share count grown?

Amplia Therapeutics has 513.3M shares on issue as at 28 Oct 2026, up 86.8% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get ATX alerts
Free for up to 2 companies. A daily email when ATX raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
20.9%
Options & rights overhang
—
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply · most strikes not on record
0
Raises · last 12 months
7.6 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 513.3M per ASX (delayed) (snapshot 28 Oct 2026).
400M450M500MDec 24Nov 25Oct 26Cash raise · 23 July 2025513.3M

Cash runway

7.6 qtrs OURS
More than four quarters of funding at the recent spend rate.
Funds operations to about Sept 2028 at the reported spend rate.
$24.6M cash after burn.
FILED 6.7 qtrs · $20.8M cash · quarter ended 30 Sept 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.FILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
16 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 Sept 2026.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
9 Sept 20263G · unquotedATX : ORDINARY FULLY PAID513.3MAppendix 3G
15 July 20263G · unquotedATX : ORDINARY FULLY PAID513.3MAppendix 3G
15 July 20263G · unquotedATX : ORDINARY FULLY PAID513.3MAppendix 3G
12 May 20262A · quoted issueATX : ORDINARY FULLY PAID513.3MAppendix 2A
10 Nov 20253G · unquotedATX : ORDINARY FULLY PAID513.1MAppendix 3G
Free account
30 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Capital raises

2 cash raises in the last 24 months · 0 in the last 12 months

every 8.7 monthsaverage gap between raises
15.2 monthssince the most recent
30 Oct 2024 – 23 July 2025first to most recent in this window
$27.6M
Placement and Share Purchase Plan
23 July 2025
Free account
3 issues (incl. 1 exercise or conversion) on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
9 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-10-28).
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

20.9%
Options & rights overhang · of current shares
—
In-the-money supply · most strikes not on record
107.1M
Potential new shares
Oct 2027
Nearest expiry
What a price move would switch on
53.6M107.1M$0.083 now0.25× today ($0.021) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.042) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.062) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.083) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.104) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.124) — 0 of the priced supply in the money, 0.0% of shares on issue2× today ($0.166) — 5.0M of the priced supply in the money, 1.0% of shares on issue3× today ($0.249) — 11.2M of the priced supply in the money, 2.2% of shares on issue5× today ($0.415) — 12.1M of the priced supply in the money, 2.3% of shares on issue10× today ($0.830) — 12.1M of the priced supply in the money, 2.3% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

An exercise price is on record for only 11.5% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $0.083 today. At double today’s price it is 5.0M (1.0% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 2.0M (1.8% of the supply above) states a nil exercise price — nothing is paid to convert it, so no share price switches it on or off. It is the flat band, and it is not part of the in-the-money figure.
  • 93.1M (86.9% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
ATXOAOptionsPrice-triggered, no exercise price stated—31 Oct 202790.3MFiling
ATXAAFOptionsPrice-triggered$0.135 June 20285.0MFiling
ATXAFOptionsPrice-triggered$0.1915 July 2028988kFiling
ATXAEOptionsPrice-triggeredNil30 Sept 2028447kFiling
ATXADOptionsPrice-triggered$0.3030 Sept 2028818kFiling
ATXAAIOptionsPrice-triggered$0.2320 Dec 20285.3MFiling
ATXAAJOptionsPrice-triggeredNil1 May 2029240kFiling
ATXAGOptionsPrice-triggeredNil15 July 20311.3MFiling
—OptionsPrice-triggered, no exercise price stated—9 Sept 20312.8MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

Free account
9 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
1 Sept 2025Christopher John BurnsOther4.2M447k——3Y notice
1 Sept 2025Dr. Robert PeachOther placement652k241k535k—3Y notice
1 Sept 2025Jane Catherine BellOther placement130k241k——3Y notice
1 Sept 2025Warwick Bonner TongOther placement152k337k——3Y notice
Free account
4 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock ATX freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.